86
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

The protective effects of simvastatin in Cadmium-Induced preosteoblast injury through Nox4

, , , , &
Pages 117-124 | Received 21 Sep 2020, Accepted 29 Nov 2020, Published online: 22 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ling Jin, Yuan Zhang, Yun Jiang, Mingjuan Tan & Caidong Liu. (2022) Circular RNA Rbms1 inhibited the development of myocardial ischemia reperfusion injury by regulating miR-92a/BCL2L11 signaling pathway. Bioengineered 13:2, pages 3082-3092.
Read now

Articles from other publishers (4)

Melissa Toyos, Rolando Toyos, Barbara Jodoin & Ryan Bunch. (2022) Results from a Prospective, Open-Label, Phase 4 Pilot Study of Repository Corticotropin Injection for Moderate and Severe Dry Eye Disease. Ophthalmology and Therapy 11:3, pages 1231-1240.
Crossref
Roy Fleischmann, Kyle Hayes, Sung-Woo Ahn, George J. Wan, Mary Panaccio, Daniel Karlsson & Daniel E. Furst. (2022) Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis. Rheumatology and Therapy 9:2, pages 649-661.
Crossref
Nagaraju Poola, Bryan Due, Dale Wright, Leah R. Brooks & Fahima Zaman. (2021) Pharmacokinetics and Pharmacodynamics of Repository Corticotropin Injection Compared With Synthetic ACTH 1‐24 Depot and Methylprednisolone in Healthy Subjects . Clinical Pharmacology in Drug Development 11:4, pages 502-515.
Crossref
Daniel Wynn, Lawrence Goldstick, William Bauer, Enxu Zhao, Eva Tarau, Jeffrey A. Cohen, Derrick Robertson & Aaron Miller. (2022) Results from a multicenter, randomized, double‐blind, placebo‐controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids. CNS Neuroscience & Therapeutics 28:3, pages 364-371.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.